Who are the main competitors in the Non-invasive Aesthetic Treatment market?

The global non-invasive aesthetic treatment market size was valued at USD 53.8 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 15.2% from 2022 to 2030. The growing focus on physical appearance among adults has led to an increased demand for non-invasive aesthetic treatments in recent years. Another key revenue-generating population to watch out for is the ones aged 50 years and above. Women, in particular, in this age group are opting for fillers and injectables including the popular Botox. According to the American Society for Aesthetic Plastic Surgery (ASAPS), in 2018, around 3.8 million minimally invasive cosmetic surgeries were carried out in the U.S. within the age group of 55 years and above. This highlights high growth prospects that lie ahead for the market in the country.

According to the International Society of Aesthetic Plastic Surgery (ISAPS), the U.S. was ranked first, in terms of non-surgical procedures performed at a global level. The country is backed by the availability of advanced treatment options and has the highest number of surgeons at a global level, with over 7,000 plastic surgeons, as per 2019 estimates. The growing consciousness about fitness and overall appearance has increased the demand for non-invasive aesthetic treatments in developing countries. In countries, such as India, these treatments are gaining consumer interest.

Gather more insights about the market drivers, restrains and growth of the Global Non-invasive Aesthetic Treatment market

The country ranks among the top 5, in terms of surgical procedures performed. Thus, developing countries are expected to be key revenue pockets for the market in the years to come. The COVID-19 pandemic has significantly affected the overall market. The cosmetics industry relies on close physical contact with their clients, leaving it negatively affected. Practitioners have also raised concerns over the downturn in patient interest owing to a sharp cut in income. The market is expected to witness a phase of short-term negative growth. Companies are expected to address this by offering maximum support to their customers.

For instance, leading player, Allergan, has assured support for its r BOTOX® operations and patient assistance. The company’s team is reachable through email communication and video conference. Recently, amidst the pandemic, remote working has increased the time spent on Zoom calls. Adults are paying attention to their physical appearance closely. This has increased the demand for cosmetic surgeries, with Botox being one of the most popular procedures preferred. Patients are also opting for cosmetic surgeries owing to ease of recovery while staying at home.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Pediatric Clinical Trials Market - The global pediatric clinical trials market size was valued at USD 14.5 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 5.1% during the forecast period. The global market has noticed critical growth on account of the rising R&D investments by pharmaceutical companies owing to the high burden of chronic and infectious diseases among the pediatrics.

Europe Mobility Aids Market - The Europe mobility aids market size was valued at USD 2.8 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 3.2% from 2022 to 2030. This growth can be attributed to the increasing geriatric population requiring Long-term Care (LTC), the growing availability of technologically advanced products, and the rising demand for home healthcare services & staff.

Non-invasive Aesthetic Treatment Market Segmentation

Grand View Research has segmented the global non-invasive aesthetic treatment market on the basis of procedure, end use, and region:

Non-invasive Aesthetic Treatment Procedure Outlook (Revenue, USD Million, 2017 - 2030)

• Injectables

o   Botulinum Toxin

o   Calcium Hydroxylapatite

o   Hyaluronic Acid

o   Polymer Filler

o   Collagen

• Skin Rejuvenation

o   Chemical Peel

o   Laser Skin Resurfacing

o   Photorejuvenation

• Others

o   Hair Removal

o   Nonsurgical Fat Reduction

o   Sclerotherapy

o   Cellulite Treatment

Non-invasive Aesthetic Treatment End-use Outlook (Revenuem, USD Million, 2017 - 2030)

• Hospital/Surgery Center
• MedSpa
• Traditional Spa
• HCP-owned Clinic

Non-invasive Aesthetic Treatment Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

o   U.S.

o   Canada

• Europe

o   U.K.

o   Germany

o   France

o   Italy

o   Spain

• Asia Pacific

o   Japan

o   China

o   India

o   Thailand

o   South Korea

• Latin America

o   Brazil

o   Mexico

o   Argentina

o   Colombia

• Middle East & Africa

o   South Africa

o   Saudi Arabia

o   UAE

 Market Share Insights

February 2021 - Sihuan Pharmaceutical Holdings Group Ltd. announced that Letybo 50U, a type of botulinum toxin for Injection, exclusively distributed by the company and produced by Hugel, Inc., has been officially approved for launch in the market by the National Medical Products Administration of the People’s Republic of China.

May 2021 -  Revance Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) plans to initiate its pre-approval inspection of the company’s manufacturing facility for DaxibotulinumtoxinA for Injection by the end of June 2021.  

Key Companies profiled:

Some prominent players in the global Non-invasive Aesthetic Treatment market include

• Hologic, Inc.
• Allergan, Inc.
• Galderma S.A.
• Alma Lasers
• Syneron Candela
• Johnson & Johnson
• MerzPharma
• Lumenis
• Solta Medical
• Cutera Inc.
• Revance Therapeutics Inc.

Order a free sample PDF of the Non-invasive Aesthetic Treatment Market Intelligence Study, published by Grand View Research.